During the past decade, Margaret and Charles Juravinski Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 18 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Margaret and Charles Juravinski Cancer Centre" #1 sponsor was "NCIC Clinical Trials Group" with 13 trials, followed by "Radiation Therapy Oncology Group" with 10 trials sponsored, "University Health Network, Toronto" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Margaret and Charles Juravinski Cancer Centre" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Margaret and Charles Juravinski Cancer Centre" are "Prostate Cancer" (11 trials), "Breast Cancer" (7 trials), "Lymphoma" (7 trials), "Lung Cancer" (5 trials) and "Brain and Central Nervous System Tumors" (3 trials). Many other conditions were trialed in "Margaret and Charles Juravinski Cancer Centre" in a lesser frequency.

Most popular intervention types in "Margaret and Charles Juravinski Cancer Centre" are "Drug" (44 trials), "Radiation" (18 trials), "Biological" (8 trials), "Procedure" (8 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (10 trials), "doxorubicin hydrochloride" (4 trials), "erlotinib hydrochloride" (4 trials), "prednisone" (4 trials) and "LHRH agonist" (3 trials). Other intervention names were less common.

The vast majority of trials in "Margaret and Charles Juravinski Cancer Centre" are 35 trials for "All" genders, 10 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Margaret and Charles Juravinski Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Margaret and Charles Juravinski Cancer Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Margaret and Charles Juravinski Cancer Centre, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".